| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net loss | |||||||||
-27,432 | -45,787 | -27,292 | -41,167 | -27,431 | - | - | - | - | - |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
4,060 | 9,292 | - | - | - | - | - | - | - | - |
Depreciation and amortization | |||||||||
4,060 | 9,292 | 9,717 | 9,092 | 8,060 | - | - | - | - | - |
Amortization of deferred financing costs | |||||||||
620 | 491 | 299 | 425 | 886 | - | - | - | - | - |
Non-cash interest | |||||||||
540 | 359 | 595 | 13,317 | 4,560 | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||
- | - | - | -1,163 | -49 | -1,250 | - | - | - | - |
Provision for doubtful accounts receivable | |||||||||
212 | 186 | 180 | 331 | 387 | - | - | - | - | - |
Inventory impairment | |||||||||
162 | 387 | 692 | 3,750 | -54 | - | - | - | - | - |
Net loss | |||||||||
- | - | - | - | - | -16,555 | -6,564 | -2,752 | -3,114 | -4,602 |
Stock based compensation | |||||||||
1,487 | 1,403 | 761 | 381 | 472 | 1,236 | 837 | 600 | 701 | 1,031 |
Unrealized foreign exchange on intercompany payables | |||||||||
214 | -1,161 | 193 | -1,332 | -522 | - | - | - | - | - |
Settlement gain | |||||||||
5,609 | 0 | - | - | - | - | - | - | - | - |
Loss on divestiture | |||||||||
0 | -7,770 | 0 | - | - | - | - | - | - | - |
Change in fair value of warrants | |||||||||
- | - | - | - | - | - | 1,000 | 2,900 | 600 | -100 |
Depreciation and amortization | |||||||||
- | - | - | - | - | 216 | 196 | 187 | 141 | 165 |
Changes in operating assets and liabilities: | |||||||||
Deferred rent expense | |||||||||
- | - | - | - | - | - | - | - | 113 | -49 |
Accounts receivable | |||||||||
-1,852 | 162 | 916 | 426 | -1,268 | -582 | 1,076 | -1,100 | -14,055 | 15,048 |
Due from related party | |||||||||
- | - | - | - | -107 | - | - | - | - | - |
Inventory | |||||||||
-872 | -3,004 | 2,850 | 3,054 | 6,352 | - | - | - | - | - |
Prepaid expenses and other assets | |||||||||
120 | -41 | -948 | -327 | 342 | 120 | -15 | -23 | 165 | -13 |
Accounts payable and accrued expenses | |||||||||
-2,052 | -1,264 | 4,739 | 3,954 | 512 | 1,101 | -179 | -839 | 1,227 | 1,602 |
Payable to related party | |||||||||
- | - | - | - | 1,449 | - | - | - | - | - |
Net cash used in operating activities | |||||||||
-25,622 | -23,119 | -13,320 | -12,901 | -16,005 | - | - | - | - | - |
Cash flows from investing activities: | |||||||||
Deferred contract revenue | |||||||||
- | - | - | - | - | -373 | -5,336 | -3,782 | -4,258 | 13,215 |
Other | |||||||||
- | - | - | - | - | 24 | 41 | -48 | 40 | 13 |
Net cash used in operating activities | |||||||||
- | - | - | - | - | -15,186 | -13,149 | -8,313 | 8,062 | -3,585 |
Purchases of property and equipment | |||||||||
805 | 1,951 | 1,564 | 1,028 | 4,763 | 105 | 44 | 154 | 134 | 1 |
Purchases of intangibles and other assets | |||||||||
175 | 930 | 573 | 1,337 | 2,019 | 430 | 346 | 189 | 354 | 466 |
Proceeds from sale of equipment | |||||||||
18 | 0 | - | - | - | - | - | - | - | - |
Divestiture of Surgical product line | |||||||||
2,000 | 10,000 | - | - | - | - | - | - | - | - |
Divestiture of Surgical product line | |||||||||
- | - | 0 | - | - | - | - | - | - | - |
Acquisitions, net of cash acquired | |||||||||
- | - | - | 200 | - | - | - | - | - | - |
Acquisitions, net of cash acquired | |||||||||
- | - | - | - | 144 | - | - | - | - | - |
Net cash used in investing activities | |||||||||
1,038 | 7,119 | -2,137 | -2,165 | -6,926 | - | - | - | - | - |
Cash flows from financing activities: | |||||||||
Net cash used in investing activities | |||||||||
- | - | - | - | - | -535 | -391 | -344 | -489 | -468 |
Proceeds from sale of common stock and warrants, net | |||||||||
- | - | - | - | - | 21,237 | 802 | 19,078 | - | 4,677 |
Proceeds from exercise of stock options | |||||||||
31 | 738 | 119 | 53 | 123 | 0 | 15 | 73 | 34 | 23 |
Proceeds from long-term debt | |||||||||
35,000 | 0 | - | - | - | - | - | - | - | - |
Proceeds from long-term debt | |||||||||
- | - | - | - | 50,000 | - | - | - | - | - |
Proceeds from convertible debt | |||||||||
20,000 | 0 | - | - | 22,166 | - | - | - | - | - |
Proceeds from issuance of common stock | |||||||||
0 | 21,857 | 33,584 | 29,000 | 0 | - | - | - | - | - |
Payments of deferred financing costs | |||||||||
2,857 | 400 | 0 | 216 | 1,088 | - | - | - | - | - |
Payment of long-term debt | |||||||||
21,668 | 12,500 | 7,000 | 11,220 | 37,717 | - | - | - | - | - |
Payment of contingent consideration | |||||||||
- | - | - | 5,000 | 0 | - | - | - | - | - |
Net cash (used in) provided by financing activities | |||||||||
30,506 | 9,695 | 26,703 | 12,617 | 33,484 | - | - | - | - | - |
Effect of exchange rate changes on cash | |||||||||
-8 | -106 | 131 | - | - | - | - | - | - | - |
Net change in cash, cash equivalents and restricted cash | |||||||||
5,914 | -6,411 | 11,377 | - | - | - | - | - | - | - |
Effect of exchange rate changes on cash | |||||||||
-8 | -106 | 131 | -96 | -216 | - | - | - | - | - |
Net decrease in cash, cash equivalents and restricted cash | |||||||||
5,914 | -6,411 | 11,377 | -2,545 | 10,337 | - | - | - | - | - |
Payment for restricted stock tax liability on net settlement | |||||||||
- | - | - | - | - | 84 | 47 | 284 | - | - |
Repayments of leasehold improvement debt | |||||||||
- | - | - | - | - | - | - | - | - | 15 |
Net cash (used in) provided by financing activities | |||||||||
- | - | - | - | - | 21,153 | 770 | 18,867 | 34 | 4,686 |
Net cash used in operating activities. | |||||||||
- | - | - | - | - | - | -12,769 | 10,210 | 7,607 | 632 |
Net increase (decrease) in cash and cash equivalents | |||||||||
- | - | - | - | - | 5,430 | - | - | - | - |
Supplemental disclosure of cash flow information: | |||||||||
Cash paid for interest | |||||||||
3,470 | 3,775 | 3,775 | - | - | - | - | - | - | - |
Cash paid for interest | |||||||||
- | - | - | 5,791 | 4,965 | - | - | - | - | - |
Cash paid for income taxes | |||||||||
328 | 98 | 274 | 318 | 49 | 1 | 1 | 1 | 1 | - |
Right-of-use assets recognized in exchange for new lease obligations (non-cash) | |||||||||
2,890 | - | - | - | - | - | - | - | - | - |
Conversion of convertible notes | |||||||||
- | - | - | 8,678 | 3,325 | - | - | - | - | - |
Reclassification of warrant liability to equity | |||||||||
- | - | - | 1,286 | 0 | - | - | - | - | - |
Warrants issued with long-term debt | |||||||||
- | - | - | - | 1,951 | - | - | - | - | - |
Accretion of dividends on preferred stock | |||||||||
- | - | - | 9,040 | 9,957 | - | - | - | - | - |
Forfeiture of dividends upon conversion of preferred stock into common stock | |||||||||
- | - | - | - | 2,304 | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||
- | - | - | -1,163 | - | -1,250 | - | - | - | - |
Change in fair value of warrant liability | |||||||||
- | - | - | - | - | - | 1,000 | 2,900 | 600 | -100 |